Trial intelligence / Profile preview

Effect of Zoledronic Acid in Primary Knee Osteoarthritis

NCT06051344Phase 4Unknown

Start
Jan 2023
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of zoledronic acid in osteoarthritis (OA). Status: unknown.

02

Drugs

zoledronic acid
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT06051344.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06051344.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call